Purpura Fulminans Induced by Disseminated Intravascular Coagulation following Infection in 2 Unrelated Children with Double Heterozygosity for Factor V Leiden and Protein S Deficiency

Summary

Purpura fulminans is associated with homozygous protein C and homozygous protein S deficiency or may follow bacterial or viral infections. We present 2 children from 2 unrelated Arab families with purpura fulminans who were double heterozygotes for factor V Leiden inherited from their fathers and protein S deficiency inherited from their mothers. No previous thrombotic events have occured in either patient or their respective family members. In one patient sepsis accompanied by disseminated intravascular coagulation appeared to be the trigger of purpura fulminans. In the other patient varicella infection preceded purpura fulminans and was also associated with disseminated intravascular coagulation. This report emphasizes the need for evaluation of hereditary defects in the inhibitory mechanisms of blood coagulation in patients with purpura fulminans at any age.

• References

• 1 Griffin JH, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
• 2 Schwarz HP, Fisher M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300
• 3 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
• 4 Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de RondeH, van derVelden P A, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 5 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993
• 6 Koster T, Rosendaal FR, de RondeH, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503-1506
• 7 Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and a coumarin-responsive chronic relapsing purpura fulminans syndrome in a neonate. Lancet 1983; 02: 1165-1168
• 8 Seligsohn U, Berger A, Abend A, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive thrombosis in the newborn. N Eng J Med 1984; 310: 559-562
• 9 Mahasandana C, Suvatte V, Marlar RA, Manco-Johnson MJ, Jacobson LJ, Hathaway WE. Neonatal purpura fulminans associated with homozygous protein S deficiency, (letter). Lancet 1990; 01: 61-62
• 10 Koeleman BP, Reitsma PH, Alaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood 1994; 84: 1031-1035
• 11 Gandrille S, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M. and The French Network on the Behalf of INSERM Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C deficient patients. Blood 1995; 86: 219-224
• 12 Pabinger I, Mustafa S, Rintelen C, Kyrle PA, Lechner K, Mannhalter C. Factor V (FV) Leiden mutation (APC-resistance) increases the risk for venous thromboembolism in patients with a gene defect of the protein C (PC) or protein S (PS) gene. Thromb Haemost 1995; 73: 1361 (abs 1763)
• 13 Zöller B, Bemsdotter A, Garcia deFrutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-3523
• 14 Borgel D, Duchemin J, Alhenc M, Matheron C, Aiach M, Gandrille S. and the French Network on the Behalf of INSERM “Molecular abnormalities responsible for protein C and protein S deficiencies” Molecular basis for protein S (PS) hereditary deficiency: genetic defects observed in 18 patients with type-I (total PS) and type-IIa (free-PS) deficiencies. J Lab Chem Med 1996; 128: 218-227
• 15 van Boven HH, Reistma PH, Rosendaal FR, Bayston TA, Chowdury V, Bauer KA, Scharrer I, Conard J, Lane DA. Factor V Leiden (FV R506Q) with inherited antithrombin III deficiency. Thromb Haemost 1996; 75: 417-421
• 16 Brenner B, Zivelin A, Lanir N, Greengard JS, Griffin JH, Seligsohn U. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. Blood 1996; 88: 877-880
• 17 Zöller B, Zuhua HE, Dahlbäck B. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease. Thromb Haemost 1995; 73: 743-745
• 18 Greengard JS, Eichinger S, Griffin JH, Bauer KA. Brief report: Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg → Gin mutation in the gene factor V. N Engl J Med 1994; 331: 1559-1562
• 19 Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 06-13
• 20 Gandrille S, Borgel D, Eschwege-Gufflet V, Aillurd MF, Dreyfus M, Matheron C, Gaussem P, Abgrall JF, Jude B, Sié P, Toulon P, Aiach M. Identification of 15 different candidate causal point mutations and 3 polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 1995; 85: 130-138
• 21 Griffin JH, Mosher DF, Zimmerman TS, Kleis AJ. Protein an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 60: 261-264
• 22 Dahlbäck B. Purification of vitamin K dependent protein S and its limited proteolysis by thrombin. Biochem J 1983; 209: 837-846
• 23 Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005
• 24 Reitsma PH, Ploos van Amstel HK, Bertina RM. Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. J Clin Invest 1994; 93: 486-492
• 25 Zöller B, Garcia de Frutos P, Dahlbäck B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995; 85: 3524-3531
• 26 Marler RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiency. Semin Thromb Haemost 1990; 16: 299-309
• 27 Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524
• 28 Powars DR, Rogers ZR, Patch MJ, McGehee WG, Francis RB. Purpura fulminans in meningococcemia, association with acquired deficiencies of protein C and S. N Engl J Med 1987; 317: 571-572
• 29 Alessi MC, Aillaud MF, Boyer-Neumann C, Viard L, Camboulives J, Juhan-Vague L. Cutaneous necrosis associated with acquired severe protein S deficiency. Thromb Haemost 1993; 69: 254
• 30 Zenz W, Muntean W. Cutaneous necrosis associated with acquired severe protein S deficiency. Thromb Haemost 1994; 71: 396
• 31 Levin M, Eley BS, Louis J, Cohen H, Young L, Heyderman RS. Postinfec-tious purpura fulminans caused by an autoantibody directed against protein S. J Pediat 1995; 127: 355-363
• 32 Spicer TE, Rau JR. Purpura Fulminans. Am J Med 1976; 61: 566-571
• 33 Westendorp RG, Reitsma PH, Bertina RM. Inherited prethrombotic disorders and infectious purpura. Thromb Haemost 1996; 75: 899-901
• 34 Faioni EM, Franchi F, Asti D, Sacchi E, Bemardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilic families: Interference in a protien S functional assay. Thromb Haemost 1993; 70: 1067-1071
• 35 Faioni EM. Another protein S functional assay is sensitive to resistance to activated protein C. Thromb Haemost 1994; 72: 643-651